Admittedly, finding the silver lining in tough situations demands mental fortitude, and can require a reasonably positive ...

Scientists develop RNA-based technology to combat plant viruses, enhancing crop immunity and reducing losses worldwide.

Researchers describe a concentric supraparticle system that protects and delivers RNA therapeutics for gene silencing in ...

Parex Resources Inc. ("Parex" or the "Company") is pleased to announce its financial and operating results for the three-month period ended March 31, 2025, the declaration of its Q2 2025 regular ...

Amgen today announced financial results for the first quarter of 2025. "Demand for our products was strong globally in the first quarter. Ongoing new product launches and successful Phase 3 trial ...

Our group retains an interest in the areas of structure-function studies of RNA interference mediated by siRNA pathway, and on post-translation ... events impacting on disease syndromes and the ...

Lipofectamine 3000 (Invitrogen, Carlsbad, CA, United States) was employed for transfection of Negative Control (NC) and DKC1 siRNA (RiboBio ... NormalizeData and ScaleData functions, followed by ...

Also in March 2025, Wave announced that the company met with the U.S. Food and Drug Administration (FDA) on WVE-N531 to ...

Dosing complete in the first two cohorts of INLIGHT trial in obesity of WVE-007 (INHBE siRNA), designed to induce healthy weight loss by reducing fat without impacting muscle; clinical data on track ...